Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer PatientsRenske M T Ten Ham, Merel van Nuland, Rick A Vreman, et al.
Clinical and Translational Science|March 31, 2021
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agenciesLourens T Bloem, Rick A Vreman, Niels W L Peeters, et al.
Drug Discovery Today|November 28, 2024
Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?Lourens T Bloem, Hubert G M Leufkens, Sophie E Berends, et al.
Drug Discovery Today|April 29, 2020
Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizationsRick A Vreman, Angela S de Ruijter, Anna Zawada, et al.
International Journal of Technology Assessment in Health Care|August 23, 2021
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreementsHans-Georg Eichler, Roisin Adams, Einar Andreassen, et al.
Frontiers in Medicine|October 10, 2022
Outcome-based reimbursement in Central-Eastern Europe and Middle-EastIldikó Ádám, Marcelien Callenbach, Bertalan Németh, et al.
Pageof 5